Key Milestones
| 2012 | 20 years of Dr. Reddy’s in Russian market |
| 2011 | • Dr. Reddy’s enters into marketing and distribution agreement with Novartis (Famvir). • Achievement of > USD 200mln sales in Russia. |
| 2010 | • Dr. Reddy’s enters into licensing agreement with Cipla (Senade). • Dr. Reddy’s enters into an agreement with R-Pharm of Russia – Collaboration in the areas of high technology and knowledge sharing. |
| 2009 | Achievement of > USD 150mln sales in Russia |
| 2008 | Achievement of > USD 100mln sales in Russia |
| 2007 | Dr. Reddy’s becomes 15th among Russian companies on retail market ( as per Pharmexpert data) |
| 2006 | Dr. Reddy’s enters into licensing agreement with MERCK AG (Germany), Molteni (Italy) and Torrent (India). |
| 2005 | Set-up OTC Field force |
| 2004 | Formed separate field force to strengthen work with hospitals |
| 2003 | Set-up Wholly Owned Subsidiary with pharmacy warehouse for better service on the territory of RF |
| 2000 | • Dr. Reddy’s increases territory of coverage: in Saratov, Volgograd, Stavropol, Chelyabinsk, Ufa, Yekaterinburg, Kemerovo, Novokuznetsk. • Nise becomes No 1 among nimesulides in RF. |
| 1998 | • Despite of economical crisis in Russia Dr. Reddy’s decides to stay back and continues to work in Russia. • Ciprolet becomes No 1 among ciprofloxacins in RF |
| 1997 | Omez becomes No. 1 among omeprazoles in Russia |
| 1992 | Dr.Reddy’s enters Russian market. Set-up Representation office in Moscow. The business is focused on participation in tenders and state supplies. |